Vasomotor and vascular effects of hormone replacement therapy

American Journal of Cardiology

Volumn 90, Issue 1 SUPPL. 1, 2002, Pages F11-F16

  Ganz, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; ASCORBIC ACID; CONJUGATED ESTROGEN; DROLOXIFENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; MEDROXYPROGESTERONE ACETATE; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROGESTERONE; RALOXIFENE; TAMOXIFEN;

ARTERY BLOOD FLOW; ARTERY CONSTRICTION; ARTERY DILATATION; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY; DRUG EFFECT; DRUG MECHANISM; ESTROGEN ACTIVITY; ESTROGEN THERAPY; HUMAN; MONKEY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0037014414     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02218-4     Document Type: Conference Paper

References (29)

1. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
2. Nitric oxide as a signaling molecule in the vascular system: An overview
3. Nitric oxide: Discovery and impact on clinical medicine
4. Endothelium-derived relaxing and contracting factors
5. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
6. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans
7. Nitric oxide activity in the atherosclerotic human coronary circulation
8. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
9. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis
10. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
11. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
12. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women
13. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women
14. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries
15. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
16. Impaired endothelial function in arterial hypertension and hypercholesterolemia: Potential mechanisms and differences
17. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
18. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
19. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: Lack of an effect of added progesterone
20. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
21. The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy
22. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
23. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women
24. Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates
25. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women
26. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis
27. Estradiol accelerates functional endothelial recovery after arterial injury
28. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
29. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: A randomized, controlled trial